Database for melanoma patients in France
French National Cohort of Patients With Melanoma (Any Stage). Network for Research and Clinical Investigation, the RIC-Mel Network.
This study is creating a database of melanoma patients in France to help researchers and doctors better understand the disease and improve treatment options.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 16000 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Nantes University Hospital Academic / other |
| Locations | 1 site (Nantes) |
| Trial ID | NCT03315468 on ClinicalTrials.gov |
What this trial studies
The RIC-Mel network is a collaborative initiative aimed at improving melanoma research by creating a comprehensive database of patients diagnosed with melanoma across France. This observational study collects key clinical data from various participating centers, including public and private dermatology and cancer centers. The database facilitates access to vital information for researchers and clinicians, promoting translational and epidemiological projects while optimizing clinical trial outcomes. The initiative is supported by prominent institutions and has received ethical approval for data confidentiality.
Who should consider this trial
Good fit: Ideal candidates for this study are patients diagnosed with melanoma at any stage who agree to participate.
Not a fit: Patients with melanoma who do not consent to participate will not benefit from this study.
Why it matters
Potential benefit: If successful, this database could enhance the understanding of melanoma and improve treatment strategies for patients.
How similar studies have performed: Other studies utilizing similar database approaches have shown success in enhancing melanoma research and treatment outcomes.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patient with melanoma, of any stage, * Patient agreed to participate. Exclusion Criteria: * Individuals under court protection
Where this trial is running
Nantes
- Nantes University Hospital — Nantes, France (Recruiting)
Study contacts
- Principal investigator: Gaëlle Quereux, PU-PH — Nantes University Hospital
- Study coordinator: Gaëlle Quereux, PU-PH
- Email: gaelle.quereux@chu-nantes.fr
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.